The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Transcatheter aortic valve implantation (TAVI) in Germany: more than 100,000 procedures and now the standard of care for the elderly

EuroIntervention 2019;14:e1549-e1552 published online December 2018. DOI: 10.4244/EIJ-D-18-01010

1. Cardioangiologisches Centrum Bethanien (CCB) at the AGAPLESION Bethanien Hospital, Frankfurt, and Department of Cardiology, Klinikum Fulda, Fulda, Germany; 2. Duke Clinical Research Institute and Duke University Medical Center, Durham, NC, USA

Following the pioneering work by Alain Cribier1, Germany has been leading the clinical adoption of transcatheter aortic valve implantation (TAVI) in Europe2 and worldwide. Since 2008, all surgical aortic valve replacements (SAVR) and all TAVI procedures are registered within a nationwide quality assurance programme providing unique insights into the development of the treatment of aortic valve stenosis since the advent of TAVI. This short report updates our previous summary (2008-2014) of the annual quality reports until 20173.

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
First-in-human experience of a new-generation transfemoral transcatheter aortic valve for the treatment of severe aortic regurgitation: the J-Valve transfemoral system